• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管加压素/催产素受体的功能结构

Functional architecture of vasopressin/oxytocin receptors.

作者信息

Hibert M, Hoflack J, Trumpp-Kallmeyer S, Mouillac B, Chini B, Mahé E, Cotte N, Jard S, Manning M, Barberis C

机构信息

Marion Merrell Dow, Strasbourg, France.

出版信息

J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):589-96. doi: 10.3109/10799899909036674.

DOI:10.3109/10799899909036674
PMID:10071787
Abstract

Three-dimensional models of G protein-coupled receptors (GPCR) have been defined using most experimental data available and protein modeling techniques. The endogenous ligand binding sites have been qualitatively described and putative receptor activation mechanisms have been proposed. The model has been recently refined to take into account recent crystallographic data. Most experimental results published are in excellent qualitative agreement with the initial model. We have undertaken to study more systematically by site directed mutagenesis the vasopressin/oxytocin receptor binding domain as a prototype of neuropeptide receptors. The experimental results are in very good agreement with the models. The residues responsible for the neuropeptide binding have been identified and confirm the predicted localization of the neuromediator in the transmembrane domain of the receptors. The side chain of the 8th residue of vasopressin interacts with a non-conserved receptor residue located in the first extracellular loop. As predicted from the model, this interaction is completely responsible for the selectivity of the ligand-receptor interaction. Finally, aromatic residues which allow the modulation of the efficacy of agonists have been identified.

摘要

利用现有的大多数实验数据和蛋白质建模技术,已确定了G蛋白偶联受体(GPCR)的三维模型。对内源性配体结合位点进行了定性描述,并提出了假定的受体激活机制。最近对该模型进行了完善,以纳入最新的晶体学数据。已发表的大多数实验结果与初始模型在质量上高度一致。我们已着手通过定点诱变更系统地研究血管加压素/催产素受体结合域,将其作为神经肽受体的一个原型。实验结果与模型非常吻合。已确定了负责神经肽结合的残基,并证实了神经介质在受体跨膜域中的预测定位。血管加压素第8位残基的侧链与位于第一个细胞外环中的一个非保守受体残基相互作用。正如从模型中预测的那样,这种相互作用完全决定了配体-受体相互作用的选择性。最后,已确定了能够调节激动剂效力的芳香族残基。

相似文献

1
Functional architecture of vasopressin/oxytocin receptors.血管加压素/催产素受体的功能结构
J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):589-96. doi: 10.3109/10799899909036674.
2
Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin.与激动剂缩宫素和卡贝缩宫素相比,选择性缩宫素受体拮抗剂巴芦米布的缩宫素受体结合结构域。
Eur J Pharmacol. 2005 Mar 7;510(1-2):9-16. doi: 10.1016/j.ejphar.2005.01.010.
3
Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.负责血管加压素与人神经垂体激素受体结合的相互作用分析——活化受体-血管加压素-G(α)系统的分子动力学研究
J Pept Sci. 2006 Mar;12(3):180-9. doi: 10.1002/psc.714.
4
Molecular dynamics simulation of human neurohypophyseal hormone receptors complexed with oxytocin-modeling of an activated state.人神经垂体激素受体与催产素复合的分子动力学模拟——活化状态建模
J Pept Sci. 2006 Mar;12(3):171-9. doi: 10.1002/psc.713.
5
Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: molecular dynamics simulation of the agonist-bound state in the membrane-aqueous system.去氨加压素与血管加压素V2受体、血管加压素V1a受体及催产素受体结合机制的研究:膜-水体系中激动剂结合状态的分子动力学模拟
Biopolymers. 2006 Apr 5;81(5):321-38. doi: 10.1002/bip.20420.
6
Molecular docking-based test for affinities of two ligands toward vasopressin and oxytocin receptors.基于分子对接的两种配体对血管加压素和催产素受体亲和力的测试。
Acta Biochim Pol. 2001;48(1):131-5.
7
Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling.鉴定参与配体结合和G蛋白偶联的神经垂体激素受体结构域。
Adv Exp Med Biol. 1998;449:371-85. doi: 10.1007/978-1-4615-4871-3_48.
8
Past, present and future of vasopressin and oxytocin receptor oligomers, prototypical GPCR models to study dimerization processes.血管加压素和催产素受体寡聚体的过去、现在和未来,是研究二聚化过程的典型 GPCR 模型。
Curr Opin Pharmacol. 2010 Feb;10(1):59-66. doi: 10.1016/j.coph.2009.10.003. Epub 2009 Nov 5.
9
Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family.血管加压素/催产素受体家族中激动剂选择性的分子基础。
Adv Exp Med Biol. 1995;395:321-8.
10
Molecular modeling of the oxytocin receptor/bioligand interactions.催产素受体/生物配体相互作用的分子建模
Acta Biochim Pol. 1999;46(3):581-90.

引用本文的文献

1
Maternal Aggression Driven by the Transient Mobilisation of a Dormant Hormone-Sensitive Circuit.由休眠的激素敏感回路的短暂激活驱动的母体攻击行为。
bioRxiv. 2024 Mar 31:2023.02.02.526862. doi: 10.1101/2023.02.02.526862.
2
Cryo-electron microscopy structure of the antidiuretic hormone arginine-vasopressin V2 receptor signaling complex.抗利尿激素精氨酸加压素V2受体信号复合物的冷冻电子显微镜结构
Sci Adv. 2021 May 21;7(21). doi: 10.1126/sciadv.abg5628. Print 2021 May.
3
Elucidating Solution Structures of Cyclic Peptides Using Molecular Dynamics Simulations.
运用分子动力学模拟阐明环肽的溶液结构。
Chem Rev. 2021 Feb 24;121(4):2292-2324. doi: 10.1021/acs.chemrev.0c01087. Epub 2021 Jan 11.
4
The impact of GPCR structures on pharmacology and structure-based drug design.G 蛋白偶联受体结构对药理学和基于结构的药物设计的影响。
Br J Pharmacol. 2010 Mar;159(5):986-96. doi: 10.1111/j.1476-5381.2009.00476.x. Epub 2009 Nov 13.
5
A vasopressin/oxytocin-related conopeptide with gamma-carboxyglutamate at position 8.一种在第8位含有γ-羧基谷氨酸的血管加压素/催产素相关芋螺肽。
Biochem J. 2007 Jun 15;404(3):413-9. doi: 10.1042/BJ20061480.
6
The 3D structure of the binding pocket of the human oxytocin receptor for benzoxazine antagonists, determined by molecular docking, scoring functions and 3D-QSAR methods.通过分子对接、评分函数和三维定量构效关系方法确定的人催产素受体与苯并恶嗪拮抗剂结合口袋的三维结构。
J Comput Aided Mol Des. 2005 May;19(5):341-56. doi: 10.1007/s10822-005-7137-0.
7
Science review: Vasopressin and the cardiovascular system part 1--receptor physiology.科学综述:血管加压素与心血管系统 第1部分——受体生理学
Crit Care. 2003 Dec;7(6):427-34. doi: 10.1186/cc2337. Epub 2003 Jun 26.
8
Molecular modeling of interactions of the non-peptide antagonist YM087 with the human vasopressin V1a, V2 receptors and with oxytocin receptors.非肽拮抗剂YM087与人血管加压素V1a、V2受体以及催产素受体相互作用的分子模拟
J Comput Aided Mol Des. 2001 Dec;15(12):1085-104. doi: 10.1023/a:1015905822671.